A change of immune profile of patients with schizophrenia during treatment

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 104, Issue 4, 2004, Pages 39-45

  Kolyaskina, G I ^a   Sekirina, T P ^a   Androsova, L V ^a   Kushner, S G ^a   Vasilyeva, E F ^a   Burbaeva, O A ^a   Morozova, M A ^a  

^a NONE

Author keywords

Cellular immunity; Cytokines; Humoral immunity; Immunological profile; Immunology; Olanzapin; Schizophrenia

Indexed keywords

AUTOANTIBODY; BENZODIAZEPINE DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; NEUROLEPTIC AGENT; OLANZAPINE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE; MALE; MIDDLE AGED; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; PHAGOCYTE; SCHIZOPHRENIA;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; AUTOANTIBODIES; BENZODIAZEPINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PHAGOCYTES; SCHIZOPHRENIA;

EID: 4944266229     PISSN: 19977298     EISSN: 19977298     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Delrahim K., Rapaport M.H. An abbreviated review of immune abnormalities in schizophrenia. CNS Spectrums 2001; 6: 392-397.
2. Ganguli R, Brar J.S., Chengappa K.N. et al. Autoimmunity in schizophrenia: A review of recent findings. Ann Med 1993; 25: 489-496.
3. Ganguli R, Brar J.S., Rabin B.S. Immune abnormalities in schizophrenia: Evidence for the autoimmune hypothesis. Harv Rev Psy-chiat 1994; 2: 70-83.
4. Kay S.R, Fiszbein A., Opler L.A. Negative symptom rating scale: limitations in psychometric and research methodology. Psychiat Res 1986; 19: 169-170.
5. Kay S.R, Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 1987; 13: 261-276.
6. Kirch D. Infection and Autoimmunity as Etiologic Factors in Schizophrenia: A Review and Reappraisal. Schizophrenia Bull 1993; 19: 2: 355-364.
7. Kolyaskina G.I., Sekirina T.P., Zozulya A.A. et al. Some aspects of immunologic studies in schizophrenia. In: Viruses, Immunity, and mental Disorders. E. Kurstak, ZJ. Lipowski, P.V. Morozov (eds). Plenum Medical Book Company. New York, London 1987; 285-294.
8. Kolyaskina G.I., Sekirina T.P., Androsova L.V. et al. Immunological studies in schizophrenia. Ann Psychiat 1996; 6: 105-122.
9. Muller N., Gruber R, Ackenheil M., Schwarz M.J. The immune system and schizophrenia. An integrative view. Ann NY Acad Sci 2000; 917: 456-467.
10. Noy S., Achiron A, Laor N. Schizophrenia and autoimmunity - a possible etiological mechanism? Neuropsycobiology 1994; 30: 157-159.
11. Rapaport M.H., McAllister C.G, Kirch D.G., Pickar D. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Biol Psychiat 1991; 29: 715-717.
12. Rapaport M.H., Muller N. Immunological states associated with schizophrenia. Psychoneuroimmunology 2001; 2: 372-382.
13. Silver H., Shmugliakov N. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study. J Clin Psychopharmacol 1998; 18: 3: 208-211.
14. Vartanian M.E, Kolyaskina G.I. A psychiatrist's view of neuroimmu-nomodulation. The neuroimmune interaction and mechanisms. Ann NY Acad Sci 1980; 496: 660-668.
15. Wang X.-F., Wang D., Zhu W. et al. Studies characterizing 60kDa autoantibodies in subjects with schizophrenia. Biol Psychiat 2003; 53: 361-375.
16. Yolken R.H., Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8: 131-145.
17. Zarrabi M.H., Zucker S, Miller F. et al. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med 1979; 91: 194-199.